Behçet’s Disease: Gastrointestinal Involvement

  • Jae Hee Cheon
  • Aykut Ferhat Çelik
  • Won Ho Kim


Reports indicate that the prevalence of gastrointestinal involvement of Behçet’s disease (BD) shows geographic variation. Since no true population surveys are available, at least some of this variation could be due to selection bias. The usually reported prevalence is less than 1% among patients from the Western countries and the Middle East while this frequency becomes 10% or higher in the Far East with reports of around 25% from Japan. As in Crohn’s disease (CD), gastrointestinal Behçet’s disease (GIBD) is seen most commonly in the ileocecal area. Lesions in the esophagus and stomach are distinctly rare. It is quite difficult to differentiate GIBD from CD disease unless other stigmata of either condition are present. The rarity of rectal involvement and the absence of granulomas in GIBD can on occasion be helpful. On the other hand, the presence of these two features in CD (∼10% for rectal disease and 10–15% for granuloma formation) is not frequent either, reducing their usefulness in differential diagnosis. Thus far, outcome perforation is more common in GIBD (25–50%) than in Crohn’s (∼2%). Management of GIBD is very similar to what we do in CD. Surgical treatment is reserved for complications like perforation, bleeding, obstruction, and stubborn fistula formation. Since relapses are frequent even under medical treatment, surgical resection should be conservative.


Anastomotic site ulcers Azatihoprine Behçet’s disease Crohn’s disease Diagnostic criteria for GIBD Enteroclysis Esophageal disease Fistulas Gastrointestinal involvement Ileocecal disease Inflammatory bowel disease Intestinal pathology Intestinal ulcers NSAID entero-colitis Prognosis Radiology Rectal involvement Recto-sigmeodoscopy Smoking Stomach involvement Surgical management Top–down therapy 


  1. 1.
    Bechgaard P (1940) Et tilfaelds af recidiverende aphtos stomatitis ledsaget af conjunctivitis og ulcerationer paa genitalia og hud. Ugeskr Laeger 102:1019–1023Google Scholar
  2. 2.
    Shimizu T, Ehrlich GE, Inaba G, Hayashi K (1979) Behçet’s disease (Behçet syndrome). Semin Arthritis Rheum 8(4):223–260PubMedCrossRefGoogle Scholar
  3. 3.
    Lee SK, Kim WH (2006) Diagnostic challenges in Asia: intestinal Behçet’s disease. Falk Symp 151:1–13Google Scholar
  4. 4.
    Yang SK (2005) Intestinal Behçet’s disease. Intest Res 3(1):1–10Google Scholar
  5. 5.
    Kaklamani VG, Vaiopoulos G, Kaklamanis PG (1998) Behçet’s disease. Semin Arthritis Rheum 27(4):197–217PubMedCrossRefGoogle Scholar
  6. 6.
    O’Duffy JD, Carney A, Deodhar S (1971) Behçet’s disease: report of 10 cases, 3 with new manifestation. Ann Intern Med 75:561–570PubMedGoogle Scholar
  7. 7.
    Eun HC, Chung H, Choi SJ (1984) Clinical analysis of 114 patients with Behçet’s disease. J Korean Med Assoc 27:933–939Google Scholar
  8. 8.
    Chamberlain MA (1977) Behçet’s syndrome in 32 patients in Yokshire. Ann Rheum Dis 36:491–499PubMedCrossRefGoogle Scholar
  9. 9.
    Dilsen N, Konice M, Aral O et al (1993) Risk factors of vital organ involvement in Behçet’s disease. In: Weschler B, Godeau F (eds) Behçet’s disease, Proceedings of the Sixth International Conference on Behçet’s Disease. Excerpta Medica, Amsterdam, pp 165–169Google Scholar
  10. 10.
    Jankowski J, Crombi I, Jankowski R (1992) Behçet’s syndrome in Scotland. Post Med J 68:566–570CrossRefGoogle Scholar
  11. 11.
    Bang D, Lee JH, Lee ES et al (2001) Epidemiologic and clinical survey of Behçet’s disease in Korea: the first multicenter study. J Korean Med Sci 16:615–618PubMedGoogle Scholar
  12. 12.
    Yurdakul S, Tuzuner N, Yurdakul I, Hamuryudan V, Yazici H (1996) Gastrointestinal involvement in Behçet’s syndrome: a controlled study. Ann Rheum Dis 55(3):208–210PubMedCrossRefGoogle Scholar
  13. 13.
    Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behçets disease: an analysis of 2147 patients. Yonsei Med J 38(6):423–427PubMedGoogle Scholar
  14. 14.
    Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behçet’s disease in Korea. Yonsei Med J 38(6):428–436PubMedGoogle Scholar
  15. 15.
    Kural-Seyahi E, Ozdogan H, Yurdakul S, Ugurlu S, Ozyazgan Y, Mat C et al (2004) The outcome of the children with Behçet’s syndrome. Clin Exp Rheumatol 22(Suppl 34):116aGoogle Scholar
  16. 16.
    Chang HK, Kim JW (2002) The clinical features of Behçet’s disease in Yongdong district: analysis of a cohort followed from 1997 to 2001. J Korean Med Sci 17:784–789PubMedGoogle Scholar
  17. 17.
    Ng FH, Cheung TC, Chow KC, Wong SY, Ng WF, Chan HC et al (2001) Repeated intestinal perforation caused by an incomplete form of Behçet’s syndrome. J Gastroenterol Hepatol 16(8):935–939PubMedCrossRefGoogle Scholar
  18. 18.
    Tursen U, Gurler A, Boyvat A (2003) Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol 42(5):346–351PubMedCrossRefGoogle Scholar
  19. 19.
    Yi SW, Cheon JH, Kim JH, Lee SK, Kim TI, Lee YC et al (2009) The prevalence and clinical characteristics of esophageal involvement in patients with Behçet’s disease: a single center experience in Korea. J Korean Med Sci 24(1):52–56PubMedCrossRefGoogle Scholar
  20. 20.
    Mizushima Y, Inaba G, Mimura Y, Ono S (1988) Diagnostic criteria for Behçet’s disease in 1987, and guidelines for treating Behçet’s disease. Saishin Igaku 43:382–391Google Scholar
  21. 21.
    Bayraktar Y, Ozaslan E, Van Thiel DH (2000) Gastrointestinal manifestations of Behçet’s disease. J Clin Gastroenterol 30(2):144–154PubMedCrossRefGoogle Scholar
  22. 22.
    Sfikakis PP (2002) Behçet’s disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61(Suppl 2):ii51–ii53PubMedGoogle Scholar
  23. 23.
    Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Yalcin B, Muftuoglu A (1980) Behçet’s disease as seen in Turkey. Haematologica 65(3):381–383PubMedGoogle Scholar
  24. 24.
    Bottomley WW, Dakkak M, Walton S, Bennett JR (1992) Esophageal involvement in Behçet’s disease. Is endoscopy necessary? Dig Dis Sci 37(4):594–597PubMedCrossRefGoogle Scholar
  25. 25.
    Houman MH, Ben Ghorbel I, Lamloum M, Khanfir M, Braham A, Haouet S et al (2002) Esophageal involvement in Behçet’s disease. Yonsei Med J 43(4):457–460PubMedGoogle Scholar
  26. 26.
    Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T (1981) Intestinal involvement in Behçet’s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum 24(2):103–106PubMedCrossRefGoogle Scholar
  27. 27.
    Ning-Sheng L, Ruay-Sheng L, Kuo-Chih T (2005) High frequency of unusual gastric/duodenal ulcers in patients with Behçet’s disease in Taiwan: a possible correlation of MHC molecules with the development of gastric/duodenal ulcers. Clin Rheumatol 24(5):516–520PubMedCrossRefGoogle Scholar
  28. 28.
    Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341(17):1284–1291PubMedCrossRefGoogle Scholar
  29. 29.
    Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H et al (1984) Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis 43(6):783–789PubMedCrossRefGoogle Scholar
  30. 30.
    Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, Song IS et al (2000) Long-term clinical course and prognostic factors in intestinal Behçet’s disease. Dis Colon Rectum 43(5):692–700PubMedCrossRefGoogle Scholar
  31. 31.
    Lee CR, Kim WH, Cho YS, Kim MH, Kim JH, Park IS et al (2001) Colonoscopic findings in intestinal Behçet’s disease. Inflamm Bowel Dis 7(3):243–249PubMedCrossRefGoogle Scholar
  32. 32.
    Kim DK, Yang SK, Byeon JS, Myung SJ, Jo JY, Choi KD et al (2005) Clinical manifestations and course of intestinal Behçet’s disease: an analysis in relation to disease subtypes. Intest Res 3(1):48–54Google Scholar
  33. 33.
    Lang BA, Laxer RM, Thorner P, Greenberg M, Silverman ED (1990) Pediatric onset of Behçet’s syndrome with myositis: case report and literature review illustrating unusual features. Arthritis Rheum 33(3):418–425PubMedCrossRefGoogle Scholar
  34. 34.
    Wu PS, Chen HL, Yang YH, Jeng YM, Lee PI, Chang MH (2005) Intestinal Behçet’s disease presenting as neonatal onset chronic diarrhea in an 11-month-old male baby. Eur J Pediatr 164(8):523–525PubMedCrossRefGoogle Scholar
  35. 35.
    Fujikawa S, Suemitsu T (1997) Behçet’s disease in children: a nationwide retrospective survey in Japan. Acta Paediatr Jpn 39(2):285–289PubMedCrossRefGoogle Scholar
  36. 36.
    Tabata M, Tomomasa T, Kaneko H, Morikawa A (1999) Intestinal Behçet’s disease: a case report and review of Japanese reports in children. J Pediatr Gastroenterol Nutr 29(4):477–481PubMedCrossRefGoogle Scholar
  37. 37.
    Bang DS, Oh SH, Lee KH, Lee ES, Lee SN (2003) Influence of sex on patients with Behçet’s disease in Korea. J Korean Med Sci 18(2):231–235PubMedGoogle Scholar
  38. 38.
    Isik B, Ara C, Kirimlioglu H, Sogutlu G, Yilmaz M, Yilmaz S et al (2005) Single or multiple perforations with varying locations as a complication of intestinal Behçet’s disease: report of three cases. Scand J Gastroenterol 40(5):599–603PubMedCrossRefGoogle Scholar
  39. 39.
    Pirildar T, Keser G, Tunc E, Alkanat M, Tuncyurek M, Doganavsargil E (2001) An unusual presentation of Behçet’s disease: intestinal perforation. Clin Rheumatol 20(1):61–62PubMedCrossRefGoogle Scholar
  40. 40.
    Lee RG (1986) The colitis of Behçet’s syndrome. Am J Surg Pathol 10(12):888–893PubMedCrossRefGoogle Scholar
  41. 41.
    Iwama T, Utzunomiya J (1977) Anal complication in Behçet’s syndrome. Jpn J Surg 7(3):114–117PubMedCrossRefGoogle Scholar
  42. 42.
    Kim SU, Cheon JH, Lim JS, Paik SH, Kim SK, Lee SK et al (2007) Massive gastrointestinal bleeding due to aneurysmal rupture of ileo-colic artery in a patient with Behçet’s disease. Korean J Gastroenterol 49(6):400–404PubMedGoogle Scholar
  43. 43.
    Smith JA, Siddiqui D (2002) Intestinal Behçet’s disease presenting as a massive acute lower gastrointestinal bleed. Dig Dis Sci 47(3):517–521PubMedCrossRefGoogle Scholar
  44. 44.
    Kim WH, Cho YS, Yoo HM, Park IS, Park EC, Lim JG (1999) Quality of life in Korean patients with inflammatory bowel diseases: ulcerative colitis, Crohn’s disease and intestinal Behçet’s disease. Int J Colorectal Dis 14(1):52–57PubMedCrossRefGoogle Scholar
  45. 45.
    Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. National cooperative Crohn’s disease study. Gastroenterology 70(3):439–444PubMedGoogle Scholar
  46. 46.
    Cheon JH, Han DS, Park JY, Ye BD, Jung SA, Young Sook Park, You Sun Kim, Joo Sung Kim, Chung Mo Nam, Youn Nam Kim, Suk-Kyun Yang, Won Ho Kim (2010). Development, Validation, and Responsiveness of a Novel Disease Activity Index for Intestinal Behçet’s Disease. Inflamm Bowel Dis (in press)Google Scholar
  47. 47.
    Mori S, Yoshihira A, Kawamura H, Takeuchi A, Hashimoto T, Inaba G (1983) Esophageal involvement in Behçet’s disease. Am J Gastroenterol 78(9):548–553PubMedGoogle Scholar
  48. 48.
    Yashiro K, Nagasako K, Hasegawa K, Maruyama M, Suzuki S, Obata H (1986) Esophageal lesions in intestinal Behçet’s disease. Endoscopy 18(2):57–60PubMedCrossRefGoogle Scholar
  49. 49.
    Anti M, Marra G, Rapaccini GL, Barone C, Manna R, Bochicchio GB et al (1986) Esophageal involvement in Behçet’s syndrome. J Clin Gastroenterol 8(5):514–519PubMedCrossRefGoogle Scholar
  50. 50.
    Brodie TE, Ochsner JL (1973) Behçet’s syndrome with ulcerative oesophagitis: report of the first case. Thorax 28(5):637–640PubMedCrossRefGoogle Scholar
  51. 51.
    Morimoto Y, Tanaka Y, Itoh T, Yamamoto S, Kurihara Y, Nishikawa K (2005) Esophagobronchial fistula in a patient with Behçet’s disease: report of a case. Surg Today 35(8):671–676PubMedCrossRefGoogle Scholar
  52. 52.
    Celik AF, Hatemi I (2005) Gastrointestinal involvement of Behçet’s syndrome. Turkiye Klinikleri J Int Med Sci 1:48–54Google Scholar
  53. 53.
    Hatemi I, Hatemi G, Celik AF, Melikoglu M, Arzuhal N, Mat C et al (2008) Frequency of pathergy phenomenon and other features of Behçet’s syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol 26(Suppl 50):S91–95PubMedGoogle Scholar
  54. 54.
    Iscimen A, Imren S, Serdaroglu S, Kutlar M et al (1987) The significance of genital scars in the diagnosis of Behçet’s syndrome. In: 11th European congress of rheumatology, Athens, Greece, June 28 to July 4, p F327Google Scholar
  55. 55.
    Mat CM, Goksungur N, Engin B, Yurdakul S, Yazici H (2006) The frequency of scarring after ulcers in Behçet’s syndrome: a prospective study. Int J Dermatol 45:554–556PubMedCrossRefGoogle Scholar
  56. 56.
    Lee SK, Kim BK, Kim TI, Kim WH (2009) Differential diagnosis of intestinal Behçet’s Disease and Crohn’s disease by colonoscopic findings. Endoscopy 41(1):9–16PubMedCrossRefGoogle Scholar
  57. 57.
    Fresko I, Ugurlu S, Ozbakır F, Celik A, Yurdakul S, Hamuryudan V et al (2005) Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet’s syndrome. Clin Exp Rheumatol 23(Suppl 38):S67–S70PubMedGoogle Scholar
  58. 58.
    Byeong GK, You SK, Joo SK, Hyun CJ, In SS (2002) Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel diseases. Dis Colon Rectum 45:1062–1069CrossRefGoogle Scholar
  59. 59.
    Kim JS, Lim SH, Choi IJ, Moon H, Jung HC, Song IS et al (2000) Prediction of the clinical course of Behçet’s colitis according to macroscopic classification by colonoscopy. Endoscopy 32(8):635–640PubMedCrossRefGoogle Scholar
  60. 60.
    Pulimood AB, Ramakrishna BS, Kurian G, Peter S, Mathan MM (1999) Endoscopic mucosal biopsies are useful in distinguishing granulomatous colitis due to Crohn’s disease from tuberculosis. Gut 45:537–541PubMedCrossRefGoogle Scholar
  61. 61.
    Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH (2008) Budd–Chiari syndrome associated with Behçet’s disease. Gastroenterol Clin Biol 32(3):316–320PubMedCrossRefGoogle Scholar
  62. 62.
    Park JJ, Cheon JH, Kim TI, Kim WH (2009) Correlation of erythrocyte sedimentation rate and C-reactive protein with clinical disease activity in intestinal Behçet’s disease. Gut58(suppl 2):A461Google Scholar
  63. 63.
    Muftuoglu AU, Yazici H, Yurdakul S, Tuzun Y, Pazarli H, Gungen G et al (1986) Behçet’s disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 25(4):235–239PubMedCrossRefGoogle Scholar
  64. 64.
    Quinton J-F, Sendid B, Reumaux D, Cortot A, Grandbastien B, Charrier G et al (1988) Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic auto-antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788–791CrossRefGoogle Scholar
  65. 65.
    Choi CH, Kim TI, Kim BC, Shin SJ, Lee SK, Kim WH et al (2006) Anti-Saccharomyces cerevisiae antibody in intestinal Behçet’s disease patients: relation to clinical course. Dis Colon Rectum 49(12):1849–1859PubMedCrossRefGoogle Scholar
  66. 66.
    Krause I, Monselise Y, Milo G, Weinberger A (2002) Anti-Saccharomyces cerevisiae antibodies – a novel serologic marker for Behçet’s disease. Clin Exp Rheumatol 20(Suppl 26):S21–S24PubMedGoogle Scholar
  67. 67.
    Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM (2007) Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn’s disease and intestinal tuberculosis. Dig Dis Sci 52(1):33–39, Epub 2006 Dec 8PubMedCrossRefGoogle Scholar
  68. 68.
    Chang DK, Kim JJ, Choi H, Eun CS, Han DS, Byeon JS et al (2007) Double balloon endoscopy in small intestinal Crohn’s disease and other inflammatory diseases such as cryptogenic multifocal ulcerous stenosing enteritis (CMUSE). Gastrointest Endosc 66(Suppl 3):S96–S98PubMedCrossRefGoogle Scholar
  69. 69.
    Hamdulay SS, Cheent K, Ghosh C, Stocks J, Ghosh S, Haskard DO (2008) Wireless capsule endoscopy in the investigation of intestinal Behçet’s syndrome. Rheumatology (Oxford) 47(8):1231–1234CrossRefGoogle Scholar
  70. 70.
    Gubler C, Bauerfeind P (2005) Intestinal Behçet’s disease diagnosed by capsule endoscopy. Endoscopy 37(7):689PubMedCrossRefGoogle Scholar
  71. 71.
    Thach BT, Cummings NA (1976) Behçet’s syndrome with “aphthous colitis”. Arch Intern Med 136(6):705–709PubMedCrossRefGoogle Scholar
  72. 72.
    Lee KS, Kim SJ, Lee BC, Yoon DS, Lee WJ, Chi HS (1997) Surgical treatment of intestinal Behçet’s disease. Yonsei Med J 38(6):455–460PubMedGoogle Scholar
  73. 73.
    Lebwohl O, Forde KA, Berdon WE, Morrison S, Challop R (1977) Ulcerative esophagitis and colitis in a pediatric patient with Behçet’s syndrome. Response to steroid therapy. Am J Gastroenterol 68(6):550–555PubMedGoogle Scholar
  74. 74.
    Korman U, Cantasdemir M, Kurugoglu S, Mihmanli I, Soylu N, Hamuryudan V et al (2003) Enteroclysis findings of intestinal Behçet’s disease: a comparative study with Crohn disease. Abdom Imaging 28(3):308–312PubMedCrossRefGoogle Scholar
  75. 75.
    Kim JH, Choi BI, Han JK, Choo SW, Han MC (1994) Colitis in Behçet’s disease: characteristics on double-contrast barium enema examination in 20 patients. Abdom Imaging 19(2):132–136PubMedCrossRefGoogle Scholar
  76. 76.
    Chung SY, Ha HK, Kim JH, Kim KW, Cho N, Cho KS et al (2001) Radiologic findings of Behçet’s syndrome involving the gastrointestinal tract. Radiographics 21(4):911–924, discussion 24–26PubMedGoogle Scholar
  77. 77.
    Ha HK, Lee HJ, Yang SK, Ki WW, Yoon KH, Shin YM et al (1998) Intestinal Behçet’s syndrome: CT features of patients with and patients without complications. Radiology 209(2):449–454PubMedGoogle Scholar
  78. 78.
    Gullberg E, Soderholm JD (2006) Peyer’s patches and M cells as potential sites of the inflammatory onset in Crohn’s disease. Ann N Y Acad Sci 1072:218–232PubMedCrossRefGoogle Scholar
  79. 79.
    Isomoto H, Shikuwa S, Suematsu T, Migita K, Ito M, Kohno S (2008) Ileal lesions in Behçet’s disease originate in Peyer’s patches: findings on magnifying endoscopy. Scand J Gastroenterol 43(2):249–250PubMedCrossRefGoogle Scholar
  80. 80.
    Takada Y, Fujita Y, Igarashi M, Katsumata T, Okabe H, Saigenji K et al (1997) Intestinal Behçet’s disease pathognomonic changes in intramucosal lymphoid tissues and effect of a “rest cure” on intestinal lesions. J Gastroenterol 32(5):598–604PubMedCrossRefGoogle Scholar
  81. 81.
    Nara K, Kurokawa MS, Chiba S, Yoshikawa H, Tsukikawa S, Matsuda T et al (2008) Involvement of innate immunity in the pathogenesis of intestinal Behçet’s disease. Clin Exp Immunol 152(2):245–251PubMedCrossRefGoogle Scholar
  82. 82.
    Hayasaki N, Ito M, Suzuki T, Ina K, Ando T, Kusugami K et al (2004) Neutrophilic phlebitis is characteristic of intestinal Behçet’s disease and simple ulcer syndrome. Histopathology 45(4):377–383PubMedCrossRefGoogle Scholar
  83. 83.
    Kobayashi M, Ito M, Nakagawa A, Matsushita M, Nishikimi N, Sakurai T et al (2000) Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology 36(4):362–371PubMedCrossRefGoogle Scholar
  84. 84.
    Zimmerman GA, Prescott SM, McIntyre TM (1992) Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 13(3):93–100PubMedCrossRefGoogle Scholar
  85. 85.
    Senturk T, Aydintug O, Kuzu I, Duzgun N, Tokgoz G, Gurler A et al (1998) Adhesion molecule expression in erythema nodosum-like lesions in Behçet’s disease. A histopathological and immunohistochemical study. Rheumatol Int 18(2):51–57PubMedCrossRefGoogle Scholar
  86. 86.
    Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T (1985) Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol 16(8):790–795PubMedCrossRefGoogle Scholar
  87. 87.
    Direskeneli H (2001) Behçet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis 60(11):996–1002PubMedCrossRefGoogle Scholar
  88. 88.
    Naganuma M, Iwao Y, Inoue N, Hisamatsu T, Imaeda H, Ishii H et al (2000) Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet’s disease. Am J Gastroenterol 95(10):2848–2851PubMedGoogle Scholar
  89. 89.
    Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C et al (2005) Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behçet’s disease. Clin Exp Immunol 139(2):371–378PubMedCrossRefGoogle Scholar
  90. 90.
    Ahmad T, Zhang L, Gogus F, Verity D, Wallace G, Madanat W et al (2005) CARD15 polymorphisms in Behçet’s disease. Scand J Rheumatol 34:233–237PubMedCrossRefGoogle Scholar
  91. 91.
    Ozen SC, Dagli U, Kilic MY, Toruner M, Celik Y, Ozkan M et al (2006) NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphism in Turkish patients with inflammatory bowel disease. J Gastroenterol 41:304–310PubMedCrossRefGoogle Scholar
  92. 92.
    Uyar FA, Over-Hamzaoglu H, Ture F, Gul A, Tozun N, Saruhan-Direskeneli G (2006) Distribution of common CARD15 variants in patients sporadic Crohn’s disease cases from Turkey. Dig Dis Sci 51(4):706–710PubMedCrossRefGoogle Scholar
  93. 93.
    Kobayashi T, Sudo Y, Okamura S, Ohashi S, Urano F, Hosoi T et al (2005) Monozygotic twins concordant for intestinal Behçet’s disease. J Gastroenterol 40(4):421–425PubMedCrossRefGoogle Scholar
  94. 94.
    Hamuryudan V, Yurdakul S, Ozbakir F, Yazici H, Hekim H (1991) Monozygotic twins concordant for Behçet’s syndrome. Arthritis Rheum 34(8):1071–1072PubMedCrossRefGoogle Scholar
  95. 95.
    Soy M, Erken E, Konca K, Ozbek S (2000) Smoking and Behçet’s disease. Clin Rheumatol 19:508–509PubMedCrossRefGoogle Scholar
  96. 96.
    Kaklamani VG, Markkomichelakis N, Kaklamanis PG (2002) Could nicotine be beneficial for Behçet’s disease. Clin Rheumatol 21:341–342PubMedCrossRefGoogle Scholar
  97. 97.
    Edward JB, Koepsell TD, Prera DR, Inuni TS (1987) Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 316:707–710CrossRefGoogle Scholar
  98. 98.
    Somerville KW, Logan RFA, Edmond M, Langman MJS (1984) Smoking and Crohn’s disease. Br Med J 289:954–956CrossRefGoogle Scholar
  99. 99.
    Fresko I, Hamuryudan V, Demir M, Hizli N, Sayman H, Melikoglu M et al (2001) Intestinal permeability in Behçet’s syndrome. Ann Rheum Dis 60(1):65–66PubMedCrossRefGoogle Scholar
  100. 100.
    Koc B, Aymelek S, Sonmez A, Yilmaz MI, Kocar H (2004) Increased sucrose permeability in Behçet’s disease. Rheumatol Int 24(6):347–350PubMedCrossRefGoogle Scholar
  101. 101.
    Kobayashi K, Ueno F, Bito S, Iwao Y, Fukushima T, Hiwatashi N et al (2007) Development of consensus statements for the diagnosis and management of intestinal Behçet’s disease using a modified Delphi approach. J Gastroenterol 42(9):737–745PubMedCrossRefGoogle Scholar
  102. 102.
    Shin SJ, Kim BC, Park SY, Kim TI, Kim WH (2005) Systemic manifestations of Behçet’s disease in diagnosis of intestinal Behçet’s disease. Gut 55:A120Google Scholar
  103. 103.
    Jung HC, Rhee PL, Song IS, Choi KW, Kim CY (1991) Temporal changes in the clinical type or diagnosis of Behçet’s colitis in patients with aphthoid or punched-out colonic ulcerations. J Korean Med Sci 6(4):313–318PubMedGoogle Scholar
  104. 104.
    Cheon JH, Kim ES, Shin SJ et al (2009) Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet’s Disease in Korean Patients with Ileo-colonic Ulcers. Am J Gastroenterol 104(10):2492–2499PubMedCrossRefGoogle Scholar
  105. 105.
    Yim CW, White RH (1985) Behçet’s syndrome in a family with inflammatory bowel disease. Arch Intern Med 145(6):1047–1050PubMedCrossRefGoogle Scholar
  106. 106.
    Kim ES, Chung WC, Lee KM, Lee BI, Choi H, Han SW et al (2007) A case of intestinal Behçet’s disease similar to Crohn’s colitis. J Korean Med Sci 22(5):918–922PubMedCrossRefGoogle Scholar
  107. 107.
    Naganuma M, Iwao Y, Kashiwagi K, Funakoshi S, Ishii H, Hibi T (2002) A case of Behçet’s disease accompanied by colitis with longitudinal ulcers and granuloma. J Gastroenterol Hepatol 17(1):105–108PubMedCrossRefGoogle Scholar
  108. 108.
    Tolia V, Abdullah A, Thirumoorthi MC, Chang CH (1989) A case of Behçet’s disease with intestinal involvement due to Crohn’s disease. Am J Gastroenterol 84(3):322–325PubMedGoogle Scholar
  109. 109.
    Smith GE, Kime LR, Pitcher JL (1973) The colitis of Behçet’s disease: a separate entity? Colonoscopic findings and literature review. Am J Dig Dis 18(11):987–1000PubMedCrossRefGoogle Scholar
  110. 110.
    International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335(8697):1078–1080Google Scholar
  111. 111.
    Balthazar EJ, Gordon R, Hulnick D (1990) Ileocecal tuberculosis: CT and radiologic evaluation. AJR Am J Roentgenol 154(3):499–503PubMedGoogle Scholar
  112. 112.
    Puspok A, Keiner H, Oberhuber G (2000) Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 43:685–691PubMedCrossRefGoogle Scholar
  113. 113.
    Laine L, Connors LG, Reicin A, Hawkey CJ, Burgos-Vagas R, Schnitzer TJ et al (2003) Serious lower gastrointestinal clinical events with nonselective NSAID or Coxib use. Gastroenterology 124:288–292PubMedCrossRefGoogle Scholar
  114. 114.
    Celik AF, Pamuk ON, Melikoglu M, Yazici H (2008) How to diagnose Behçet’s and intestinal Behçet’s disease? In: Tozun N, Mantzaris, Daglı U, Schölmerich J (eds) IBD 2007-achievements in research and clinical practice. Springer, Dordrecht, pp 118–128CrossRefGoogle Scholar
  115. 115.
    Kurahara K, Matsumoto T, Iida M, Honda K, Yao T, Fujishima M (2001) Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations. Am J Gastroenterol 96(2):473–480PubMedCrossRefGoogle Scholar
  116. 116.
    Iida M (1992) Clinical course of intestinal lesions in patients with intestinal disease and simple ulcer. Stomach Intestine 27:287–302Google Scholar
  117. 117.
    Pallis AG, Mouzas IA, Vlachonikolis IG (2004) The inflammatory bowel disease questionnaire: a review of its national validation studies. Inflamm Bowel Dis 10(3):261–269PubMedCrossRefGoogle Scholar
  118. 118.
    Park KD, Bang D, Lee ES, Lee SH, Lee S (1993) Clinical study on death in Behçet’s disease. J Korean Med Sci 8(4):241–245PubMedGoogle Scholar
  119. 119.
    Yoo HM, Han KH, Kim PS, Kim WH, Kang JK, Park IS et al (1997) Clinical features of intestinal Behçet’s disease and therapeutic effects of sulfasalazine. Korean J Gastroenterol 29:465–472Google Scholar
  120. 120.
    Houman MH, Hamzaoui K (2006) Promising new therapies for Behçet’s disease. Eur J Intern Med 17(3):163–169PubMedCrossRefGoogle Scholar
  121. 121.
    Sonta T, Araki Y, Koubokawa M, Tamura Y, Ochiai T, Harada N et al (2000) The beneficial effect of mesalazine on esophageal ulcers in intestinal Behçet’s disease. J Clin Gastroenterol 30(2):195–199PubMedCrossRefGoogle Scholar
  122. 122.
    Matsukawa M, Yamasaki T, Kouda T, Kurihara M (2001) Endoscopic therapy with absolute ethanol for postoperative recurrent ulcers in intestinal Behçet’s disease, and simple ulcers. J Gastroenterol 36(4):255–258PubMedCrossRefGoogle Scholar
  123. 123.
    Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S et al (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet’s syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128(6):443–450PubMedGoogle Scholar
  124. 124.
    Bariol C, Meagher AP, Vickers CR, Byrnes DJ, Edwards PD, Hing M et al (2002) Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease. J Gastroenterol Hepatol 17(2):135–139PubMedCrossRefGoogle Scholar
  125. 125.
    Yasui K, Uchida N, Akazawa Y, Nakamura S, Minami I, Amano Y et al (2008) Thalidomide for treatment of intestinal involvement of juvenile-onset Behçet’s disease. Inflamm Bowel Dis 14(3):396–400PubMedCrossRefGoogle Scholar
  126. 126.
    Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL (2001) Treatment of intestinal Behçet’s syndrome with chimeric tumour necrosis factor alpha antibody. Gut 49(5):725–728PubMedCrossRefGoogle Scholar
  127. 127.
    Kram MT, May LD, Goodman S, Molinas S (2003) Behçet’s ileocolitis: successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy: report of a case. Dis Colon Rectum 46(1):118–121PubMedCrossRefGoogle Scholar
  128. 128.
    Lee JH, Kim TN, Choi ST, Jang BI, Shin KC, Lee SB et al (2007) Remission of intestinal Behçet’s disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab). Korean J Intern Med 22(1):24–27PubMedCrossRefGoogle Scholar
  129. 129.
    Byeon JS, Choi EK, Heo NY, Hong SC, Myung SJ, Yang SK et al (2007) Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet’s disease: report of a case. Dis Colon Rectum 50(5):672–676PubMedCrossRefGoogle Scholar
  130. 130.
    Naganuma M, Sakuraba A, Hisamatsu T, Ochiai H, Hasegawa H, Ogata H et al (2008) Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet’s disease. Inflamm Bowel Dis 14(9):1259–1264PubMedCrossRefGoogle Scholar
  131. 131.
    Hanauer SB (2003) Crohn’s disease: step up or top down therapy. Best Pract Res Clin Gastroenterol 17(1):131–137PubMedCrossRefGoogle Scholar
  132. 132.
    Mussack T, Landauer N, Ladurner R, Schiemann U, Goetzberger M, Burchardi C et al (2003) Successful treatment of cervical esophageal perforation in Behçet’s disease with drainage operation and infliximab. Am J Gastroenterol 98(3):703–704PubMedCrossRefGoogle Scholar
  133. 133.
    Ju JH, Kwok SK, Seo SH, Yoon CH, Kim HY, Park SH (2007) Successful treatment of life-threatening intestinal ulcer in Behçet’s disease with infliximab: rapid healing of Behçet’s ulcer with infliximab. Clin Rheumatol 26(8):1383–1385PubMedCrossRefGoogle Scholar
  134. 134.
    Rossi G, Moretta A, Locatelli F (2004) Autologous hematopoietic stem cell transplantation for severe/refractory intestinal Behçet’s disease. Blood 103(2):748–750PubMedCrossRefGoogle Scholar
  135. 135.
    Yamato K (2003) Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet’s disease. Int J Hematol 77(1):82–85PubMedCrossRefGoogle Scholar
  136. 136.
    Sayek I, Aran O, Uzunalimoglu B, Hersek E (1991) Intestinal Behçet’s disease: surgical experience in seven cases. Hepatogastroenterology 38(1):81–83PubMedGoogle Scholar
  137. 137.
    Lida M, Kobayayashi H, Matsumoto T, Okada M, Fuchigami T, Yao T et al (1994) Postoperative recurrence in patients with intestinal Behçet’s disease. Dis Colon Rectum 37(1):16–21CrossRefGoogle Scholar
  138. 138.
    Bozkurt M, Torin G, Aksakal B, Ataoglu O (1992) Behçet’s disease and surgical intervention. Int J Dermatol 31(8):571–573PubMedCrossRefGoogle Scholar
  139. 139.
    Bradbury AW, Milne AA, Murie JA (1994) Surgical aspects of Behçet’s disease. Br J Surg 81(12):1712–1721PubMedCrossRefGoogle Scholar
  140. 140.
    Chung MJ, Cheon JH, Kim SU, Park JJ, Kim TI, Kim NK (2010) Response rates to medical treatments and long-term clinical outcomes of non-surgical patients with intestinal Behçet’s disease. J Clin Gastroenterol Jan 5 [Epub ehead of print]Google Scholar
  141. 141.
    Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V et al (2003) The long term mortality and morbidity of Behçet’s syndrome. A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76CrossRefGoogle Scholar
  142. 142.
    Uyar FA, Saruhan-Direskeneli G, Gül A (2004) Common Crohn’s disease predisposing variants of the CARD15/NOD2 genes are not associated with Behçet’s disease in Turkey. Clin Exp Rheumatol 22(Suppl 34):S50–S52PubMedGoogle Scholar
  143. 143.
    Hatemi I, Hatemi G, Senateş, Baysal B, Erzin Y, Celik AF (2008) Low dose thalidomide in immunosuppressive unresponsive IBD; effectiveness and side effects. Gastroenterology 132:4(Suppl 2):A665Google Scholar
  144. 144.
    Yamamoto T, Toyokkawa H, Matsubara JT et al (1974) A nation-wide survey of Behçet’s disease in Japan. I. Epidemiological survey. Jpn J Opthalmol 18:282–290Google Scholar
  145. 145.
    Cigerciogulları E, Goksel S, Dogusoy B, Erdamar S, Celik AF, Erzin Y et al (2005) An analysis of the reliability of detection and diagnostic value of various pathologic features in Crohn’s disease. Virchows Arch 447(2):P5O7Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Jae Hee Cheon
  • Aykut Ferhat Çelik
    • 1
  • Won Ho Kim
  1. 1.Division of Gastroenterology, Department of Internal MedicineUniversity of IstanbulIstanbulTurkey

Personalised recommendations